Sight Sciences, Verana Health collaborate on glaucoma research

Verana Health and Sight Sciences announced a research collaboration designed to provide insights that may lead to improved outcomes for patients with primary open-angle glaucoma. Sight Sciences will leverage Verana Health’s Qdata Glaucoma RWD module to evaluate various facets of its OMNI Surgical System – a minimally invasive, implant-free glaucoma procedure that uniquely addresses all three known points of resistance in the aqueous outflow system: the trabecular meshwork, Schlemm’s canal and the collector channels. Intraocular Pressure is the only known modifiable risk factor for glaucoma, and OMNI enables surgeons to reduce IOP while avoiding more aggressive surgical interventions or foreign body implants associated with legacy minimally invasive glaucoma surgery procedures. OMNI is indicated for canaloplasty followed by trabeculotomy, and can be used before, in combination with, or following cataract surgery.